GRM1 Gene Spinocerebellar Ataxia Type 13 Autosomal Recessive Genetic Test sale cost 4400 AED
PLEKHG5 Gene Spinal Muscular Atrophy Distal Autosomal Recessive Type 4 Genetic Test sale cost 4400 AED PLEKHG5 Gene Spinal Muscular Atrophy Distal Autosomal Recessive Type 4 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
ATXN8OS Gene Spinocerebellar Ataxia Type 8 Autosomal Dominant Genetic Test sale cost 4400 AED ATXN8OS Gene Spinocerebellar Ataxia Type 8 Autosomal Dominant Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

GRM1 Gene Spinocerebellar Ataxia Type 13 Autosomal Recessive Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GRM1 gene, associated with Spinocerebellar Ataxia Type 13 (SCA13), plays a crucial role in the development and function of the cerebellum, which is responsible for coordinating movement. Mutations in this gene can lead to SCA13, a condition characterized by progressive problems with movement, including poor coordination, unsteady walking, and involuntary eye movements. This condition is inherited in an autosomal recessive pattern, meaning that an individual must receive a mutated gene from both parents to be affected.

In the United Arab Emirates, DNA Labs UAE offers a genetic test specifically designed to identify mutations in the GRM1 gene that cause Spinocerebellar Ataxia Type 13. This test is critical for individuals with a family history of the condition or those exhibiting symptoms, as it can provide a definitive diagnosis. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for the presence of mutations in the GRM1 gene.

The cost of the GRM1 gene test at DNA Labs UAE is 4400 AED. This test is an important tool for genetic counseling, helping families understand the risk of passing the condition to future generations. It also assists healthcare professionals in managing and treating the condition more effectively, by tailoring interventions to the specific needs of individuals with SCA13.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GRM1 Gene Spinocerebellar Ataxia Type 13 Autosomal Recessive Genetic Test

Are you or your loved one experiencing progressive problems with movement and coordination? DNA Labs UAE offers the GRM1 Gene Spinocerebellar Ataxia Type 13 Autosomal Recessive Genetic Test to help diagnose this rare genetic disorder.

Test Components and Price

The test costs AED 4400.0 and requires a blood or extracted DNA sample. Alternatively, one drop of blood on an FTA Card can also be used.

Report Delivery

After the sample is received, the report will be delivered within 3 to 4 weeks.

Method

The GRM1 Gene Spinocerebellar Ataxia Type 13 Autosomal Recessive Genetic Test utilizes NGS (Next-Generation Sequencing) technology.

Test Type and Doctor

This test is specifically designed for the diagnosis of neurological disorders, and it is recommended to consult with a neurologist.

Test Department

The test is conducted in the Genetics department of DNA Labs UAE.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by GRM1 Gene Spinocerebellar Ataxia Type 13 Autosomal Recessive.

Test Details

Spinocerebellar Ataxia Type 13 (SCA13) is a rare genetic disorder characterized by progressive problems with movement and coordination. It is caused by mutations in the GRM1 gene, which is responsible for producing a protein called metabotropic glutamate receptor 1 (mGluR1). In order for an individual to develop SCA13, both copies of the GRM1 gene must be mutated, making it an autosomal recessive disorder.

The GRM1 Gene Spinocerebellar Ataxia Type 13 Autosomal Recessive Genetic Test uses NGS technology to analyze multiple genes simultaneously and identify mutations or variants that may be responsible for the disorder. By sequencing the GRM1 gene, this test provides a definitive diagnosis of SCA13 in individuals displaying symptoms consistent with the disorder. It can also be used for carrier testing in individuals with a family history of SCA13 to identify those who have one mutated copy of the GRM1 gene but do not exhibit symptoms.

It is crucial to undergo genetic testing for SCA13 under the guidance of a healthcare professional or genetic counselor. They can provide the necessary counseling and support before and after the test.

Don’t let the uncertainty continue. Take the first step towards a definitive diagnosis with the GRM1 Gene Spinocerebellar Ataxia Type 13 Autosomal Recessive Genetic Test offered by DNA Labs UAE.

Test Name GRM1 Gene Spinocerebellar ataxia type 13 autosomal recessive Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GRM1 Gene Spinocerebellar ataxia type 13, autosomal recessive NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GRM1 Gene Spinocerebellar ataxia type 13, autosomal recessive
Test Details

Spinocerebellar ataxia type 13 (SCA13) is a rare genetic disorder characterized by progressive problems with movement and coordination. It is caused by mutations in the GRM1 gene, which provides instructions for making a protein called metabotropic glutamate receptor 1 (mGluR1).

Autosomal recessive means that both copies of the GRM1 gene must be mutated for an individual to develop SCA13. This means that an affected individual must inherit one mutated copy of the gene from each parent.

Next-generation sequencing (NGS) genetic testing is a method used to analyze multiple genes simultaneously and identify mutations that may be responsible for a particular genetic disorder. In the case of SCA13, an NGS genetic test can be used to sequence the GRM1 gene and identify any mutations or variants that may be present.

The purpose of the test is to provide a definitive diagnosis of SCA13 in individuals who have symptoms consistent with the disorder. It can also be used for carrier testing in individuals with a family history of SCA13, as it can identify individuals who have one mutated copy of the GRM1 gene but do not show symptoms of the disorder.

It is important to note that genetic testing for SCA13 should be done under the guidance of a healthcare professional or genetic counselor, as they can provide appropriate counseling and support before and after the test.

SKU: TEST-2057 Category:

Related products